BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17357163)

  • 1. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
    Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
    Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteochemometric analysis of small cyclic peptides' interaction with wild-type and chimeric melanocortin receptors.
    Kontijevskis A; Petrovska R; Mutule I; Uhlen S; Komorowski J; Prusis P; Wikberg JE
    Proteins; 2007 Oct; 69(1):83-96. PubMed ID: 17557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes.
    Lapinsh M; Veiksina S; Uhlén S; Petrovska R; Mutule I; Mutulis F; Yahorava S; Prusis P; Wikberg JE
    Mol Pharmacol; 2005 Jan; 67(1):50-9. PubMed ID: 15470082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
    Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
    Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
    Fleck BA; Ling N; Chen C
    Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of the potent cyclic and linear melanocortin analogues.
    Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
    J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
    Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
    Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogs of alpha-melanocyte stimulating hormone with high agonist potency and selectivity at human melanocortin receptor 1b: the role of Trp(9) in molecular recognition.
    Bednarek MA; Macneil T; Tang R; Fong TM; Angeles Cabello M; Maroto M; Teran A
    Biopolymers; 2008 May; 89(5):401-8. PubMed ID: 17926329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expressions of melanocortin receptor subtypes in melanophores and xanthophores of barfin flounder.
    Kobayashi Y; Tsuchiya K; Yamanome T; Schiöth HB; Takahashi A
    Gen Comp Endocrinol; 2010 Aug; 168(1):133-42. PubMed ID: 20417636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic analogs of alpha-melanocyte-stimulating hormone (alphaMSH) with high agonist potency and selectivity at human melanocortin receptor 1b.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    Peptides; 2008 Jun; 29(6):1010-7. PubMed ID: 18378043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationships and conformational properties of alpha-MSH(6-13) analogues with candidacidal activity.
    Carotenuto A; Saviello MR; Auriemma L; Campiglia P; Catania A; Novellino E; Grieco P
    Chem Biol Drug Des; 2007 Jan; 69(1):68-74. PubMed ID: 17313459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The melanocortin system in Fugu: determination of POMC/AGRP/MCR gene repertoire and synteny, as well as pharmacology and anatomical distribution of the MCRs.
    Klovins J; Haitina T; Fridmanis D; Kilianova Z; Kapa I; Fredriksson R; Gallo-Payet N; Schiöth HB
    Mol Biol Evol; 2004 Mar; 21(3):563-79. PubMed ID: 14694081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
    Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
    Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.